» Articles » PMID: 30721278

Achieving Clinical Remission for Patients With Rheumatoid Arthritis

Overview
Journal JAMA
Specialty General Medicine
Date 2019 Feb 6
PMID 30721278
Citations 8
Authors
Affiliations
Soon will be listed here.
Citing Articles

Preferences for Tapering Biologic Disease-Modifying Antirheumatic Drugs Among People With Rheumatoid Arthritis: A Discrete Choice Experiment.

Chan S, Stamp L, Treharne G, Cheung J, Dalbeth N, Grainger R Arthritis Care Res (Hoboken). 2024; 77(3):349-358.

PMID: 39308004 PMC: 11848995. DOI: 10.1002/acr.25437.


Comparison of rheumatoid arthritis composite disease activity indices and residual activity in a Brazilian multicenter study- REAL study.

Santos I, de Oliveira R, Couto Luna Almeida S, Vargas-Santos A, Balbino Chaves Amorim R, Gomides A PLoS One. 2022; 17(9):e0273789.

PMID: 36174077 PMC: 9521837. DOI: 10.1371/journal.pone.0273789.


Inflammation-Triggered Supramolecular Nanoplatform for Local Dynamic Dependent Imaging-Guided Therapy of Rheumatoid Arthritis.

Li L, Wang X, Gao R, Zhang B, Liu Y, Zhou J Adv Sci (Weinh). 2022; 9(7):e2105188.

PMID: 35023331 PMC: 8895155. DOI: 10.1002/advs.202105188.


Prediction of disease flare by biomarkers after discontinuing biologics in patients with rheumatoid arthritis achieving stringent remission.

Kameda H, Hirata A, Katagiri T, Takakura Y, Inoue Y, Takenaka S Sci Rep. 2021; 11(1):6865.

PMID: 33767314 PMC: 7994312. DOI: 10.1038/s41598-021-86335-7.


LncRNA NEAT1 Targets Fibroblast-Like Synoviocytes in Rheumatoid Arthritis via the miR-410-3p/YY1 Axis.

Wang Y, Hou L, Yuan X, Xu N, Zhao S, Yang L Front Immunol. 2020; 11:1975.

PMID: 32983133 PMC: 7485383. DOI: 10.3389/fimmu.2020.01975.